Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Andersen, Vibeke ^a   Christensen, Jane ^b   Overvad, Kim ^c   Tjønneland, Anne ^b   Vogel, Ulla ^d,e,f  

^a VIBORG HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f ROSKILDE UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER X RECEPTOR BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PREGNANE X RECEPTOR; THREONINE; CELL RECEPTOR; DNA; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PEROXISOME TARGETING SIGNAL 1 RECEPTOR; PEROXISOME-TARGETING SIGNAL 1 RECEPTOR;

ADULT; ALLELE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DRUG USE; FEMALE; FOOD INTAKE; GENE DELETION; GENE INSERTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RED MEAT; SMOKING HABIT; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL TUMOR; DIET; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS;

CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DIET; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; ORPHAN NUCLEAR RECEPTORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77956483124     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-484     Document Type: Article

References (64)

1. Huxley RR, nsary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009, 125:171-180. 10.1002/ijc.24343, 19350627.
2. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 2009, 15:425-430. 10.1158/1078-0432.CCR-08-0149, 19147746.
3. World Resources Institue, Earth Trends, The environmental information portal. 2009, Ref Type: Internet Communication., http://earthtrends.wri.org/
4. World Cancer Research Fund/American Institute for CancerResearch FNPAatoCaGPA. 2007, Washington, DC, Ref Type: Internet Communication., http://www.dietandcancerreport.org/
5. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 2008, 60:131-144. 10.1080/01635580701684872, 2661797, 18444144.
6. Oates PS, West AR. Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility. World J Gastroenterol 2006, 12:4281-4295.
7. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009, 124:2406-2415. 10.1002/ijc.24191, 19142968.
8. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009, 7:682-688. 10.1016/j.cgh.2009.02.016, 19245853.
9. WHO Regional Office for Europe. Tobacco control database. 2009, Ref Type: Internet Communication., http://data.euro.who.int/tobacco/
10. Richard P, Lopez Alan D, Jillian B, Thun M. Mortality from smoking in developed contries 1950-2000. 2009, Ref Type: Internet Communication., http://www.ctsu.ox.ac.uk/~tobacco
11. Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford) 2007, 46:93-96. 10.1093/rheumatology/kel175, 16720636.
12. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007, 369:1603-1613. 10.1016/S0140-6736(07)60747-8, 17499602.
13. Friis S, Poulsen AH, Sorensen HT, Tjonneland A, Overvad K, Vogel U, et al. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study. Cancer Causes Control 2009,
14. Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G. Aspirin, salicylates, and cancer. Lancet 2009, 373:1301-1309. 10.1016/S0140-6736(09)60243-9, 19328542.
15. Stark LA, Din FV, Zwacka RM, Dunlop MG. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 2001, 15:1273-1275.
16. Goel A, Boland CR. Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol 2009,
17. Vogel U, Christensen J, Dybdahl M, Friis S, Hansen RD, Wallin H, et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 2007, 624:88-100.
18. Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, Hamfjord J, et al. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med Genet 2009, 10:18. 10.1186/1471-2350-10-18, 2662819, 19250544.
19. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, et al. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res 2007, 619:68-80.
20. Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, Vogel U. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 2009, 9:407. 10.1186/1471-2407-9-407, 2797527, 19930591.
21. Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene 2003, 22:7496-7511. 10.1038/sj.onc.1206950, 14576854.
22. Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, et al. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Pharmacogenet Genomics 2008, 18:439-448. 10.1097/FPC.0b013e3282f974dc, 18408567.
23. Teng S, Piquette-Miller M. Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm 2008, 5:67-76. 10.1021/mp700102q, 18072749.
24. Chisaki I, Kobayashi M, Itagaki S, Hirano T, Iseki K. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver. Biochim Biophys Acta 2009, 1788:2396-2403. 10.1016/j.bbamem.2009.08.014, 19728987.
25. Wang D, DuBois RN. Inflammatory mediators and nuclear receptor signaling in colorectal cancer. Cell Cycle 2007, 6:682-685.
26. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436. 10.1038/nature04870, 16724054.
27. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008, 659:15-30. 10.1016/j.mrrev.2008.03.002, 18485806.
28. Sebban H, Courtois G. NF-kappaB and inflammation in genetic disease. Biochem Pharmacol 2006, 72:1153-1160. 10.1016/j.bcp.2006.08.006, 16965764.
29. De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, et al. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut 2007, 56:524-533. 10.1136/gut.2006.096487, 1856846, 16950831.
30. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007, 130:918-931. 10.1016/j.cell.2007.07.009, 2134986, 17803913.
31. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13:35-45. 10.1093/hmg/ddh008, 14613970.
32. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, Arbman G, et al. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol 2007, 42:1332-1338. 10.1080/00365520701396026, 17852842.
33. di MA, Marinis ED, Ascenzi P, Marino M. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med 2009, 30:297-343. 10.1016/j.mam.2009.04.002, 19427329.
34. Zhou C, Tabb MM, Nelson EL, Grun F, Verma S, Sadatrafiei A, et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 2006, 116:2280-2289. 10.1172/JCI26283, 1501109, 16841097.
35. Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, et al. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 2001, 11:555-572. 10.1097/00008571-200110000-00003, 11668216.
36. Rizzo G, Fiorucci S. PPARs and other nuclear receptors in inflammation. Curr Opin Pharmacol 2006, 6:421-427. 10.1016/j.coph.2006.03.012, 16777482.
37. Infante J, Rodriguez-Rodriguez E, Mateo I, Llorca J, Vazquez-Higuera JL, Berciano J, et al. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk. Neurobiol Aging 2008,
38. Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007, 35:432-441. 10.1080/14034940601047986, 17786808.
39. Hansen R, Saebo M, Skjelbred CF, Nexo BA, Hagen PC, Bock G, et al. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 2005, 229:85-91. 10.1016/j.canlet.2005.04.019, 15946795.
40. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, et al. A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study. BMC Cancer 2008, 8:54. 10.1186/1471-2407-8-54, 18289367.
41. Foodcalc 1.3 Computer program 1998. 2009, , http://www.foodcalc.com
42. Prosky L, Asp NG, Furda I, DeVries JW, Schweizer TF, Harland BF. Determination of total dietary fiber in foods and food products: collaborative study. J Assoc Off Anal Chem 1985, 68:677-679.
43. Tjonneland A, Overvad K, Haraldsdottir J, Bang S, Ewertz M, Jensen OM. Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 1991, 20:906-912. 10.1093/ije/20.4.906, 1800429.
44. Tjonneland A, Haraldsdottir J, Overvad K, Stripp C, Ewertz M, Jensen OM. Influence of individually estimated portion size data on the validity of a semiquantitative food frequency questionnaire. Int J Epidemiol 1992, 21:770-777. 10.1093/ije/21.4.770, 1521982.
45. Friis S, Poulsen AH, Sorensen HT, Tjonneland A, Overvad K, Vogel U, et al. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control 2009, 20:731-740. 10.1007/s10552-008-9286-7, 19122977.
46. Vogel U, Christensen J, Dybdahl M, Friis S, Hansen RD, Wallin H, et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 2007, 624:88-100.
47. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
48. Vangsted AJ, Klausen TW, Ruminski W, Gimsing P, Andersen NF, Gang AO, et al. The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplant 2009, 43:539-545. 10.1038/bmt.2008.351, 18997828.
49. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999, 52:1165-1172. 10.1016/S0895-4356(99)00102-X, 10580779.
50. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994, 50:1064-1072. 10.2307/2533444, 7786988.
51. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, et al. A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study. BMC Cancer 2008, 8:54. 10.1186/1471-2407-8-54, 2263058, 18289367.
52. Raaschou-Nielsen O, Sorensen M, Overvad K, Tjonneland A, Vogel U. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2007,
53. Raaschou-Nielsen O, Sorensen M, Hansen RD, Frederiksen K, Tjonneland A, Overvad K, et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett 2007, 247:293-300. 10.1016/j.canlet.2006.05.006, 16797832.
54. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Raaschou-Nielsen O, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 2008, 639:89-100.
55. Sorensen M, Raaschou-Nielsen O, Hansen RD, Tjonneland A, Overvad K, Vogel U. Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 2006, 40:885-891. 10.1080/10715760600733129, 17015267.
56. Vogel U, Segel S, Dethlefsen C, Tjonneland A, Saber AT, Wallin H, et al. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010, 209:155-162. 10.1016/j.atherosclerosis.2009.08.036, 19748095.
57. Vogel U, Segel S, Dethlefsen C, Tjonneland A, Saber AT, Wallin H, et al. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes. BMC Med Genet 2009, 10:52. 10.1186/1471-2350-10-52, 2698834, 19500413.
58. Jensen MK, Rimm EB, Mukamal KJ, Edmondson AC, Rader DJ, Vogel U, et al. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 2009, 30:1584-1589. 10.1093/eurheartj/ehp145, 2733737, 19411665.
59. Jensen MK, Rimm EB, Rader D, Schmidt EB, Sorensen TI, Vogel U, et al. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am Heart J 2009, 157:384-390. 10.1016/j.ahj.2008.10.008, 19185650.
60. Legrand-Poels S, Zecchinon L, Piret B, Schoonbroodt S, Piette J. Involvement of different transduction pathways in NF-kappa B activation by several inducers. Free Radic Res 1997, 27:301-309. 10.3109/10715769709065768, 9350434.
61. Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, et al. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006, 130:341-348. 10.1053/j.gastro.2005.12.008, 16472590.
62. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 2006, 46:123-149. 10.1146/annurev.pharmtox.46.120604.141059, 16402901.
63. Wang K, Wan YJ. Nuclear receptors and inflammatory diseases. Exp Biol Med (Maywood) 2008, 233:496-506. 10.3181/0708-MR-231, 18375823.
64. Din FV, Dunlop MG, Stark LA. Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis. Br J Cancer 2004, 91:381-388. 2409803, 15188000.